Community Bank & Trust Waco Texas Has $218,000 Position in Monsanto Co. (MON)
Community Bank & Trust Waco Texas reduced its position in Monsanto Co. (NYSE:MON) by 16.5% during the second quarter, Holdings Channel reports. The firm owned 2,105 shares of the company’s stock after selling 415 shares during the period. Community Bank & Trust Waco Texas’ holdings in Monsanto were worth $218,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Howard Hughes Medical Institute purchased a new position in shares of Monsanto during the first quarter worth about $110,000. Bartlett & Co. LLC increased its position in shares of Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock worth $145,000 after buying an additional 134 shares during the period. Carnick & Kubik LLC purchased a new position in shares of Monsanto during the first quarter worth about $130,000. Palladium Partners LLC purchased a new position in shares of Monsanto during the second quarter worth about $205,000. Finally, First Quadrant L P CA increased its position in shares of Monsanto by 42.9% in the second quarter. First Quadrant L P CA now owns 2,000 shares of the company’s stock worth $207,000 after buying an additional 600 shares during the period. Hedge funds and other institutional investors own 79.02% of the company’s stock.
Shares of Monsanto Co. (NYSE:MON) traded up 0.26% during midday trading on Monday, hitting $102.47. 1,945,370 shares of the stock were exchanged. The firm’s 50 day moving average price is $105.05 and its 200-day moving average price is $101.18. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26. The stock has a market cap of $44.84 billion, a P/E ratio of 45.10 and a beta of 1.19.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.11%. Monsanto’s payout ratio is presently 89.26%.
A number of research analysts have recently issued reports on the stock. Monness Crespi & Hardt dropped their price target on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating on the stock in a research report on Monday. S&P Equity Research reiterated a “positive” rating on shares of Monsanto in a research note on Thursday, September 15th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Monsanto in a research note on Thursday, June 30th. Zacks Investment Research lowered shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Friday, July 1st. Finally, Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price objective for the company in a research note on Wednesday, August 3rd. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $114.21.
In other news, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.